No abstract

This review article summarizes the current medical literature reporting on the prevalence and prognostic significance of anemia in patients with heart failure. Almost all currently available data indicate that anemia is common in heart failure populations, with the majority of studies indicating prevalence >20%. Anemia appears to be more highly prevalent in patients with advanced age, with more severe limitations in functional capacity, and with greater severity of co-morbid chronic kidney disease. In most reported studies anemia is an independent predictor of increased mortality risk and increased risk of hospitalization for heart failure. These data provide the rationale for interventional treatment trials to determine if anemia is in the causal pathway for disease progression and increased mortality risk in HF patients.

No abstract

Background: The mechanism and characteristics of early and late drug-eluting stent in-stent restenosis (DES-ISR) have not been fully clarified. Whether there are different outcomes among those patients being irrespective of their repeated treatments remain a knowledge gap. Methods: A total of 250 patients who underwent initial stent implantation in our hospital, and then were readmitted to receive treatment for the reason of recurrent significant DES-ISR in 2016 were involved. The patients were categorized as early ISR (<12 months; E-ISR; n = 32) and late ISR (≥12 months; L-ISR; n = 218). Associations between patient characteristics and clinical performance, as well as clinical outcomes after a repeated percutaneous coronary intervention (PCI) were evaluated. Primary composite endpoint of major adverse cardiac events (MACEs) included cardiac death, non-fatal myocardial infarction (MI), or target lesion revascularization (TLR). Results: Most baseline characteristics are similar in both groups, except for the period of ISR, initial pre-procedure thrombolysis in myocardial infarction, and some serum biochemical indicators. The incidence of MACE (37.5% vs . 5.5%; P < 0.001) and TLR (37.5% vs . 5.0%; P < 0.001) is higher in the E-ISR group. After multivariate analysis, E-ISR (odds ratio [OR], 13.267; [95% CI 4.984–35.311]; P < 0.001) and left ventricular systolic dysfunction (odds ratio [OR], 6.317; [95% CI 1.145–34.843]; P = 0.034) are the independent predictors for MACE among DES-ISR patients in the mid-term follow-up of 12 months. Conclusions: Early ISR and left ventricular systolic dysfunction are associated with MACE during the mid-term follow-up period for DES-ISR patients. The results may benefit the risk stratification and secondary prevention for DES-ISR patients in clinical practice.

Background It is ill‐defined which factors affect the prognosis of patients with recanalized chronic total occlusion (CTO). This study sought to investigate predictors for adverse outcome in such a cohort with long‐time follow‐up. Methods From 2010 to 2013, patients with successfully recanalized CTO were included. The primary endpoint was a composite of all‐cause death, myocardial infarction or target vessel revascularization (TVR). The secondary endpoints were TVR and target lesion revascularization (TLR). Results A total of 1987 patients were enrolled and 1806 (90.6%) subjects completed 5‐year follow‐up. Multivariate Cox analysis revealed that age ≥ 75 years (HR,1.70; 95% CI, 1.09‐2.64; P = .02), left ventricular ejection fraction <40% (HR, 1.94; 95% CI, 1.02‐3.69; P = .04) and residual SYNTAX score (HR, 1.02; 95% CI, 1.01‐1.04; P = .01) were predictors for the primary endpoint. Non‐LAD CTO (HR, 1.82; 95% CI, 1.23‐2.70; P < .01), J‐CTO score (HR, 1.31; 95% CI, 1.11‐1.54; P < .01) and residual SYNTAX score (HR, 1.02; 95% CI, 1.00‐1.04; P = .04) were independently related to TVR. Non‐LAD CTO, high J‐CTO score and residual SYNTAX score was also correlated with TLR. Conclusions Advanced age, left ventricular dysfunction and residual SYNTAX score were predictors for composite cardiovascular events in patients with CTO after revascularization. Those with non‐LAD CTO, high J‐CTO and residual SYNTAX score had higher risk for revascularization.